GGrantIndex
← Leaderboards

Michelle L Hermiston

University Of California San Francisco

$3,634,874
Attributed
$7,716,390
Total exposure
3
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $851.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,716,390 · 3

By mechanism

R01$7,334,880 · 2
K08$381,510 · 1

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseCellsT-LymphocyteMutationSignal TransductionSignal PathwayBiochemicalPhenotypeGeneticProteasome InhibitorInternationalHigh RiskPediatric Oncology GroupPathway InteractionsProteinsGenesBone MarrowClinical TrialsChemotherapyBiologyDisease-Free SurvivalCytotoxic ChemotherapyChildBortezomib

Grant awards (16)

Improving risk allocation and developing novel therapies for children with T-ALL and T-LL$737,926
R01 · FY2025 · CA
Improving risk allocation and developing novel therapies for children with T-ALL and T-LL$721,069
R01 · FY2024 · CA
Improving risk allocation and developing novel therapies for children with T-ALL and T-LL$851,561
R01 · FY2023 · CA
Improving risk allocation and developing novel therapies for children with T-ALL$575,456
R01 · FY2019 · CA
Improving risk allocation and developing novel therapies for children with T-ALL$594,741
R01 · FY2018 · CA
Improving risk allocation and developing novel therapies for children with T-ALL$625,779
R01 · FY2017 · CA
Improving risk allocation and developing novel therapies for children with T-ALL$626,176
R01 · FY2016 · CA
Improving risk allocation and developing novel therapies for children with T-ALL$709,314
R01 · FY2015 · CA
Interplay of Innate and Adaptive Immunity in Lupus Pathogenesis$382,388
R01 · FY2014 · AI · contact PI
Interplay of Innate and Adaptive Immunity in Lupus Pathogenesis$359,444
R01 · FY2013 · AI · contact PI
Interplay of Innate and Adaptive Immunity in Lupus Pathogenesis$382,388
R01 · FY2012 · AI · contact PI
Interplay of Innate and Adaptive Immunity in Lupus Pathogenesis$382,388
R01 · FY2011 · AI · contact PI
Interplay of Innate and Adaptive Immunity in Lupus Pathogenesis$386,250
R01 · FY2010 · AI · contact PI
Role of CD45 in Hematopoiesis and Lymphomagenesis$127,170
K08 · FY2005 · CA
Role of CD45 in Hematopoiesis and Lymphomagenesis$127,170
K08 · FY2004 · CA
Role of CD45 in Hematopoiesis and Lymphomagenesis$127,170
K08 · FY2003 · CA